Table 1 provides a detailed comparison of clinical and biochemical characteristics of study patients classified as either responders or non-responders as described above. Notably, depression and cognitive function did not show any significant modification in both groups during the six months protocol. Interestingly, DTSQs increased whereas TNFα levels decreased only in responders (Table 1). This evidence concerns the gene TNF and depressive disorder.